Autoimmune diseases induced by TNF-targeted therapies
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 22 (5) , 847-861
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Autoimmune Diseases Induced by TNF-Targeted TherapiesMedicine, 2007
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Vasculitis in Systemic Lupus ErythematosusMedicine, 2006
- Musculoskeletal manifestations and autoimmune diseases related to new biologic agentsCurrent Opinion in Rheumatology, 2006
- Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti–tumor necrosis factor agents infliximab and etanerceptArthritis & Rheumatism, 2005
- Safety and efficacy of over 7 years of etanercept therapy in a global population of patients with rheumatoid arthritisJournal of the American Academy of Dermatology, 2005
- Efficacy, Tolerability and Cost Effectiveness of Disease-Modifying Antirheumatic Drugs and Biologic Agents in Rheumatoid ArthritisDrugs, 2005
- Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patientsArthritis & Rheumatism, 2004
- Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexateArthritis & Rheumatism, 2004
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994